TransMedics Group, Inc. ( TMDX ) is set to have a very strong 2026 growth year. More specifically, I believe that throughout 2026, TMDX will post accelerating revenues, thereby allowing the stock to inflect higher.Michael Wiggins De Oliveira is an Inflection investor. As an Inflection investor, I believe that simplicity is key to outperformance. Since 2024, Deep Value Returns is up 174% vs 58% for the Nasdaq (*as of 6 January 2026).This means buying a stock at the moment when the outlook is expected to impr ...